Abstract:To develop a new interventional oncology technique, "radiofrequency hyperthermia (RFH)-enhanced herpes simplex virus thymidine kinase (GFP/HSV-TK)/ganciclovir (GCV) gene therapy of cholangiocarcinoma." Luciferase/mCherry-labeled cholangiocarcinoma cells and 24 mice with subcutaneously implanted cholangiocarcinoma cells were treated by: (i) a combination of green fluorescent protein (GFP)/HSV-TK/plasmid gene transfection followed by RFH and ganciclovir exposure; (ii) gene therapy alone; (iii) RFH alone; and (iv) phosphate-buffered saline (PBS) to serve as a control (6 mice per group). Cell viabilities were quantified by MTS assay. Bioluminescent optical imaging and transcutaneous ultrasound imaging were used to follow up the tumor growth over 2 weeks. For in-vivo technical validation of the new technique, pigs in two groups received either intrabiliary delivery of GFP/HSV-TK/plasmid using a needle-integrated balloon catheter flowed by RFH enhancement (n = 6) or gene delivery only (n = 6). GFP signal in bile duct walls were quantified by optical imaging.The non- parametric Mann-Whitney U test was used for statistical comparison of variables. MTS assay demonstrated the lowest cell proliferation in combination therapy compared with three control groups (24.0 ± 5.3% vs 41.9 ± 6.4% vs 72.0 ± 9.0% vs 100%, p<0.001). GFP optical imaging confirmed that GFP/HSV-TK gene expression peaked at day 2 after gene transfection. Bioluminescent optical imaging demonstrated the decreased bioluminescence signals in tumors of combination therapy, compared with other control groups (0.71 ± 0.16 vs 1.46 ± 0.21 vs 2.10 ± 0.27 vs 2.36 ± 0.28, p<0.001). Ultrasound imaging showed the smallest tumor volumes of the combination therapy group, compared with other groups (0.90 ± 0.21 VS 1.61 ± 0.21 VS 2.22 ± 0.25 VS 2.50 ± 0.30, p<0.001). optical imaging confirmed higher GFP expression in the bile ducts with RFH enhancement (signal to noise ratio: 1.28 ± 0.61 VS 0.49 ± 0.31, P<0.05). It is feasible to use intratumoral RFH to enhance GFP/HSV-TK/plasmid gene expression and HSV-TK/GCV gene therapy of cholangiocarcinomas.This concept may pave a new avenue for managing pancreatobiliary malignancies.(supported by an NIH RO1EBO12467)

An Optimized Telomerase-Specific Lentivirus For Optical Imaging Of Tumors

Noninvasive and real-time monitoring of the therapeutic response of tumors in vivo with an optimized hTERT promoter.

Early Tumor Detection Afforded by in Vivo Imaging of Near-Infrared Ii Fluorescence

Immortalization of Human Umbilical Vein Endothelial Cells by Transfected with Htert and SV40LT

[In-Vivo Tumor Imaging by Radiolabeled RNA Probe Targeting Telomerase].

Construction of a Tumor-Specific Bioluminescent Eukaryotic Expression Vector and Analysis of Its Expression in Vitro and in Vivo

Ratiometric Fluorescent Biosensor for Visual Discrimination of Cancer Cells with Different Telomerase Expression Levels.

An Activatable Nanoscintillator Probe for Detecting Telomerase Activity and Screening Inhibitors in Vivo

Optical Imaging: Bacteria, Viruses, and Mammalian Cells Encoding Light-Emitting Proteins Reveal the Locations of Primary Tumors and Metastases in Animals

Advance in Intracellular Telomerase Imaging for Cancer Diagnosis and Therapy

Intrabiliary Radiofrequency Heating-Enhanced Direct Intratumoral GFP/HSV-TK Gene Therapy of Cholangiocarcinoma: A Preclinical Study on Mice and Pigs

Abstract No. 576 Orthotopic Ovarian Cancer: Molecular Imaging-Monitored Radiofrequency Hyperthermia-Enhanced Intratumoral Herpes Simplex Virus-Thymidine Kinase (HSV-TK) Gene Therapy

Cholangiocarcinoma: molecular imaging-guided radiofrequency hyperthermia-enhanced intratumoral herpes simplex virus thymidine kinase gene therapy.

Expression Activity of Cancer-Specific Adenovirus Vector Targeting Telomerase

[Construction of Tumor Cell-Specific Expression Vector Modulated by Human Telomerase Reserse Transcription Gene Core Promoter].

A Novel Ohsv-1 Targeting Telomerase Reverse Transcriptase-Positive Cancer Cells Via Tumor-Specific Promoters Regulating the Expression of ICP4

Detection of Cell Cycle- and Differentiation Stage-Dependent Human Telomerase Reverse Transcriptase Expression in Single Living Cancer Cells

Fluorescence-guided assessment of bone and soft-tissue sarcomas for predicting the efficacy of telomerase-specific oncolytic adenovirus

Fluorescence Imaging of Intracellular Telomerase Activity for Tumor Cell Identification by Oligonucleotide-Functionalized Gold Nanoparticles

Construction of lentiviral expression vector with telomerase reverse transcriptase and green fluorescent protein recombinant gene

Targeting Visualization of Malignant Tumor Based on the Alteration of DWI Signal Generated by Htert Promoter–driven AQP1 Overexpression